Explore every episode of the podcast Sifted Studio

Europe’s AI opportunity is a new podcast mini-series brought to you by Sifted and Nebius, an AI infrastructure company building full-stack cloud for the AI era. 

Over the next three episodes, Sifted’s senior reporter Daphné Leprince-Ringuet will be exploring the potential of AI for Europe’s enterprises.

This episode focuses on what the AI opportunity looks like for Europe in the next few years — what are Europe’s AI founders focusing on to differentiate themselves in the AI race, what they need to scale and stand a chance against their competitors and why, ultimately, investors betting on European AI.

Joining the conversation were Tom Blackwell, chief communications officer at Nebius, Albane Dersy, cofounder and COO of Inbolt, Steffen Tjerrild, cofounder of Synthesia, and Philippe Botteri, partner at global investor Accel.

Europe's AI opportunity is a new podcast mini-series is brought to you by Sifted and Nebius, an AI infrastructure company building full-stack cloud for the AI era.

Over the next three episodes, Sifted's senior reporter Daphné Leprince-Ringuet will be exploring the potential of AI for Europe's enterprises.

This episode was recorded live from VivaTech in Paris — France’s flagship tech event that brings together startups, corporates and industrial leaders. 

This episode focuses on whether, and how, European enterprises are adopting AI, and what this means for the AI startups they partner with — or, in some cases, don’t.

Joining the conversation were Claire Nouet, cofounder and COO of Pathway, Olivier Gomez, cofounder and CEO of IAC.AI, and Anubhav Maheshwari, head of venture partnerships at Nebius.

We discussed the most effective ways to measure and communicate trust in AI systems, how existing frameworks can help validate new AI systems and how the technology poses new questions for mitigating risk. 

Participating in the discussion were: 

• Song Hwee Chia, deputy CEO of Temasek, a global investment firm headquartered in Singapore.
• Sebastian Hallensleben, chief trust officer at AI test lab Resaro.
• Dr Kerim Galal, executive vice president at corporate development across strategy, AI, M&A and in-house consulting at German machine tools and laser tech company Trumpf.
• Dr Frauke Goll, managing director at the AppliedAI Institute for Europe GmbH.

Europe's AI opportunity is a new podcast mini-series is brought to you by Sifted and Nebius, an AI infrastructure company building full-stack cloud for the AI era. 

Over the next three episodes, Sifted's senior reporter Daphné Leprince-Ringuet will be exploring the potential of AI for Europe's enterprises.

This week, she unpacks Europe’s position in the AI race — its ambitions, gaps and what role infrastructure plays when it comes to building the next generation of AI leaders — with special guests, Roman Chernin, cofounder and chief business officer of Nebius, Thomas Wolf, cofounder and chief science officer at Hugging Face, and Jonas Andrulis, founder and CEO of Aleph Alpha.

Drug discovery and development is an arduous, expensive process that usually results in failure. An estimated 90% of clinical drugs don’t make it to market, after an R&D process that can take as long as 15 years, and cost up to $2bn. 

With AI, those numbers could be dramatically improved. Drug development could become more efficient, clinical trials could happen faster and production processes could be optimised so that every batch is just right. But to drive progress and unlock billions of dollars in value, the pharmaceutical sector needs to learn how to use AI-powered technologies at scale. 

Sanofi, a global pharmaceutical and healthcare company headquartered in Paris, is one company which recognises this. It recently announced the launch of a new digital manufacturing and supply (M&S) accelerator in Lyon, where Sanofi employees will use AI to find and scale new innovations that will deliver life-changing treatments to patients faster, sometimes in partnership with startups.  

Daphné Leprince-Ringuet, Sifted’s senior French tech reporter, sat down with Emmanuel Frenehard, chief digital officer, Sanofi, and Brendan O’Callaghan, executive vice president for manufacturing and supply, Sanofi, to find out more. 

Every week, startup life reporter Anisah Osman Britton will be sitting down with resilient founders and expert investors to discuss operating in a downturn. From what we can learn from previous financial crises to the anatomy of mergers and acquisitions, we'll be getting top tips on how to survive during tough economic times — and what to be optimistic about. This podcast is brought to you by EQT Ventures and Sifted.

Every week, startup life reporter Anisah Osman Britton will be sitting down with resilient founders and expert investors to discuss operating in a downturn. From what we can learn from previous financial crises to the anatomy of mergers and acquisitions, we'll be getting top tips on how to survive during tough economic times — and what to be optimistic about. This podcast is brought to you by EQT Ventures and Sifted.

Every week, startup life reporter Anisah Osman Britton will be sitting down with resilient founders and expert investors to discuss operating in a downturn. From what we can learn from previous financial crises to the anatomy of mergers and acquisitions, we'll be getting top tips on how to survive during tough economic times — and what to be optimistic about. This podcast is brought to you by EQT Ventures and Sifted.

Every week, startup life reporter Anisah Osman Britton will be sitting down with resilient founders and expert investors to discuss operating in a downturn. From what we can learn from previous financial crises to the anatomy of mergers and acquisitions, we'll be getting top tips on how to survive during tough economic times — and what to be optimistic about. This podcast is brought to you by EQT Ventures and Sifted.